Adopting Bioimilars: Practical Considerations

Show Description +

David Brown, MD, offers his take on how to integrate biosimilars into practice, what the ideal patient profile looks like, and what the potential economic impact could be for practices adopting biosimilars.

Posted: 4/14/2023

Keywords:

biosimilars

Biogen

Adopting Bioimilars: Practical Considerations

David Brown, MD, offers his take on how to integrate biosimilars into practice, what the ideal patient profile looks like, and what the potential economic impact could be for practices adopting biosimilars.

Posted: 4/14/2023

Keywords:

biosimilars

Biogen

Resources

Biosimilars in Retinal Disease Management

View Resource

About Biogen

One of the world’s first global biotechnology companies, Biogen, was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Biogen is commercializing biosimilars and transforming the standard of care for patients in several areas of high unmet need.